TANDEM

MHz Choice and Topic Streaming Services Unwrap the Perfect Holiday Gift for International Series Lovers with Returning Seasons of Fan Favorites and a Holiday Sale

Retrieved on: 
Thursday, November 30, 2023

WASHINGTON, Nov. 30, 2023 /PRNewswire/ -- This holiday season, streaming services MHz Choice and Topic are bringing viewers a stocking full of international series, with new seasons of fan favorite returning series and a holiday sale, along with new series premieres.

Key Points: 
  • WASHINGTON, Nov. 30, 2023 /PRNewswire/ -- This holiday season, streaming services MHz Choice and Topic are bringing viewers a stocking full of international series, with new seasons of fan favorite returning series and a holiday sale, along with new series premieres.
  • Distributor: Federation Studios
    Dec. 26: WALKING ON SUNSHINE Season 3 (MHz Choice) – A smart and saucy Austrian comedy-drama set in a TV weather department.
  • And in our HOLIDAY SALE, new MHz Choice subscribers get 40% off an annual subscription and new Topic subscribers get 50%.
  • And explore our MHz Choice Holiday Mood collection here: https://watch.mhzchoice.com/holiday-mood

InventHelp Inventor Develops Tandem Slide Stopper for Commercial Trailers (ITM-170)

Retrieved on: 
Wednesday, August 9, 2023

PITTSBURGH, Aug. 9, 2023 /PRNewswire/ -- "As a truck driver, I was frustrated with repeated attempts to slide tandems on trailers into proper position for legal weight distribution at the axles," said an inventor, from Canyonville, Ore., "so I invented the TANDEM SLIDE STOPPER.

Key Points: 
  • PITTSBURGH, Aug. 9, 2023 /PRNewswire/ -- "As a truck driver, I was frustrated with repeated attempts to slide tandems on trailers into proper position for legal weight distribution at the axles," said an inventor, from Canyonville, Ore., "so I invented the TANDEM SLIDE STOPPER.
  • The patent-pending invention provides a precise way to position a trailer's axels.
  • In doing so, it eliminates the need to repeatedly walk between the tractor cab and trailer to check pin positioning.
  • The original design was submitted to the National sales office of InventHelp.

TANDEM study shows potential of HistoIndex SHG/TPE imaging and AI-based technology in evaluating the effects of combination therapy for NASH

Retrieved on: 
Thursday, June 15, 2023

The study, published recently in Hepatology , compared the effectiveness of Tropifexor plus Cenicriviroc combination therapy versus monotherapy1.

Key Points: 
  • The study, published recently in Hepatology , compared the effectiveness of Tropifexor plus Cenicriviroc combination therapy versus monotherapy1.
  • The study found that the AI-based analysis using SHG/TPE digital pathology was able to detect effects seen in different zones of the liver lobule that may not have been detected using conventional microscopy.
  • The fully quantitative co-localization and zonal assessment has the potential to provide greater details in evaluating the effects of combination therapy for NASH.
  • Tropifexor is a selective agonist of farnesoid X receptor (FXR), which regulates bile acid metabolism and inflammation.

Vor Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update

Retrieved on: 
Thursday, March 23, 2023

In December 2022, Vor Bio announced the pricing of an underwritten offering and a private placement, with combined gross proceeds of approximately $115.8 million.

Key Points: 
  • In December 2022, Vor Bio announced the pricing of an underwritten offering and a private placement, with combined gross proceeds of approximately $115.8 million.
  • The Company intends to evaluate VCAR33ALLO in combination with trem-cel as a Treatment System, aiming at prolonged remissions or cures following transplant.
  • General & Administrative (G&A) Expenses: G&A expenses for the fourth quarter of 2022 were $7.7 million, compared to $5.6 million for the fourth quarter of 2021, and for the year ended December 31, 2022, were $28.9 million, compared to $21.5 million for the year ended December 31, 2021.
  • Net Loss: Net loss for the fourth quarter of 2022 was $23.9 million, compared to $18.3 million for the fourth quarter of 2021, and for the year ended December 31, 2022, was $92.1 million, compared to $68.9 million for the year ended December 31, 2021.

Arcade1Up Announces Terminator 2: Judgment Day Home Arcade Machine

Retrieved on: 
Tuesday, October 26, 2021

MIAMI, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Tastemakers LLCs Arcade1Up, the leader in home retro gaming entertainment, announces fan favorite, Terminator 2: Judgment Day.

Key Points: 
  • MIAMI, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Tastemakers LLCs Arcade1Up, the leader in home retro gaming entertainment, announces fan favorite, Terminator 2: Judgment Day.
  • Arcade1Ups latest at-home arcade machine transports fans back to the 90s when visionary director, James Cameron, changed cinema 30 years ago with the movie Terminator 2: Judgment Day.
  • "The original game, developed by Midway, was a blockbuster hit and now 30 years later, Arcade1Up is thrilled to celebrate this title in a home arcade machine for Terminator fans.
  • Exciting features consumers can bring home with the Terminator 2 home arcade machine include:
    2 in 1: The home arcade machine comes with Terminator 2: Judgment Day and exclusive behind the scenes footage on how the Terminator 2 game was made!